CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to JHPCY

Camrelizumab plus apatinib Cohort B

Phase 2
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR (JHPCY)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Gestational Trophoblastic Neoplasia

View Full Landscape
Drug Information

Target Indication

Gestational Trophoblastic Neoplasia

Clinical Trial

NCT05139095

Last updated: 11/1/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.